Skip to content
Search

Latest Stories

GPhC advises pharmacists to meet regulatory standard to curb risks relating to online services

The General Pharmaceutical Council (GPhC) has raised concerns over the rising risks related to online pharmacy services.

It revealed over 30 per cent of its open Fitness to Practise (FtP) cases were related to online pharmacy, which is disproportionate to the sector of the market that online services occupy.


The regulator has advised pharmacists and pharmacy owners providing online services that they should "not work with online providers who try to circumvent the regulatory oversight put in place within the UK to ensure patient safety".

In the past five months, the Council has imposed seven interim orders on the registration of pharmacists who have worked for or with online prescribing services -- after identifying serious concerns with their practice.

It said: “These pharmacists were working as pharmacist independent prescribers for online services or were dispensing medicines prescribed online. Some of these pharmacists were the Responsible Pharmacist (RP) or the Superintendent Pharmacist (SP).”

The Council continues with its FtP investigations and has a number of ongoing investigations into other pharmacists working for online services and expects to take further action.

The common themes in these cases include- medicines being prescribed to patients on the basis of an online questionnaire alone, with no direct interaction between the prescriber and either the patient or their GP; prescribing of high-risk medications or medications which require monitoring without adequate safeguards; prescribing of medicines outside the prescriber’s scope of practice; and high volumes of prescriptions being issued by the prescriber in short periods of time.

"We have also taken enforcement action against over 50 online pharmacies since March 2019 after identifying patient safety issues during inspections. Only 71 per cent of online pharmacies that we inspected from 2019-22 met all of our standards for registered pharmacies, compared to an overall benchmark of 85 per cent for all pharmacies," GPhC said in its letter to pharmacy owners.

GPhC added: “We are writing to make you aware of serious patient safety concerns we are continuing to identify relating to some online pharmacies and online prescribing services, and the action we’re taking in response.”

All pharmacists are advised to meet GPhC standards for pharmacy professionals at all times, including one working for an online pharmacy or prescribing service. They should also seek assurances that the service is following the relevant parts of GPhC guidance on providing pharmacy services at a distance, including on the internet.

The Council has advised pharmacist independent prescribers to make sure they follow GPhC guidance for pharmacist prescribers when prescribing.

“You are responsible for making sure that the medicines you prescribe are clinically appropriate for patients and that you are always working within the scope of your practice,” the GPhC said.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less